Skip to main content
Clinical Trials/ACTRN12617001281381
ACTRN12617001281381
Withdrawn
未知

Retinal Vein Occlusion Study: Branch vs Hemicentral. A study to show whether hemi-central retinal vein occlusions (hemi-CRVO) resolve quicker and require less treatment with anti-VEGF injections by developing more haemodynamically efficient collateral circulation much earlier than branch retinal vein occlusions (BRVO).

ions Eye Institute0 sites42 target enrollmentStarted: September 6, 2017Last updated:

Overview

Phase
未知
Status
Withdrawn
Sponsor
ions Eye Institute
Enrollment
42

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • 1\. Dry macula for three months following anti\-VEGF treatment.
  • 2\. Access to participants medical notes including Fluorescein angiograms (FA).

Exclusion Criteria

  • 1\. Inability to fixate for OCT\-A image acquisition.

Investigators

Sponsor
ions Eye Institute

Similar Trials